LogicBio Therapeutics - Stock Price History | LOGC
Historical daily share price chart and data for LogicBio Therapeutics since 2021 adjusted for splits. The latest closing stock price for LogicBio Therapeutics as of October 15, 2021 is 4.00.
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
- The all-time high LogicBio Therapeutics stock closing price was 17.98 on November 23, 2018.
- The LogicBio Therapeutics 52-week high stock price is 9.74, which is 143.5% above the current share price.
- The LogicBio Therapeutics 52-week low stock price is 3.72, which is 7% below the current share price.
- The average LogicBio Therapeutics stock price for the last 52 weeks is 5.98.
|LogicBio Therapeutics Historical Annual Stock Price Data
||Average Stock Price
||Annual % Change
||Medical - Biomedical and Genetics
LogicBio Therapeutics Inc. is a genome editing company. It focuses on developing medicines to treat rare diseases in patients with significant unmet medical needs. The company's technology platform consists of GeneRide(TM). LogicBio Therapeutics Inc. is based in Cambridge, Massachusetts.